Cary Street Partners Investment Advisory’s Titan Medical Inc. Ordinary Shares TMDI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,000
Closed -$1.32K 1737
2022
Q4
$1.32K Buy
+2,000
New +$1.05K ﹤0.01% 1556

Other funds holding TMDI

Cary Street Partners Investment Advisory's TMDI Position: Q1 2023 in Review

Cary Street Partners Investment Advisory sold out of Titan Medical Inc. Ordinary Shares (TMDI) in Q1 2023, closing a stake of 2,000 shares — an estimated $1.32K sold.

Cary Street Partners Investment Advisory first reported a position in TMDI in Q4 2022 and held it in 1 quarter. The position peaked at $1.32K in Q4 2022. 12 funds tracked by Wall St. Rank hold TMDI as of Q1 2023.

  • Cary Street Partners Investment Advisory reported no remaining Titan Medical Inc. Ordinary Shares position as of Q1 2023 after selling out during the quarter.
  • Cary Street Partners Investment Advisory sold 2,000 Titan Medical Inc. Ordinary Shares shares in Q1 2023, an estimated $1.32K.
  • Cary Street Partners Investment Advisory first reported a position in Titan Medical Inc. Ordinary Shares in Q4 2022 and held it in 1 quarter.
  • Cary Street Partners Investment Advisory's Titan Medical Inc. Ordinary Shares position peaked at $1.32K in Q4 2022.
  • 12 funds tracked by Wall St. Rank held Titan Medical Inc. Ordinary Shares as of Q1 2023.

Based on Cary Street Partners Investment Advisory's 13F filing for Q1 2023, filed 12 May 2023.